Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Rabies HELP
Based on 2,495 articles published since 2008
||||

These are the 2495 published articles about Rabies that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Compendium of Animal Rabies Prevention and Control, 2016. 2016

Anonymous5010858 / Anonymous5020858 / Brown, Catherine M / Slavinski, Sally / Ettestad, Paul / Sidwa, Tom J / Sorhage, Faye E. · ·J Am Vet Med Assoc · Pubmed #26885593.

ABSTRACT: -- No abstract --

2 Guideline Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice. 2010

Anonymous1970666. · ·Ann Emerg Med · Pubmed #20648715.

ABSTRACT: -- No abstract --

3 Guideline Monkey bite exposure treatment protocol. 2010

Newton, Frank / Anonymous4580655. ·Headquarters Special Operations Command Pacific, Camp Smith, Hawaii, USA. ·J Spec Oper Med · Pubmed #20306415.

ABSTRACT: -- No abstract --

4 Guideline Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. 2008

Manning, Susan E / Rupprecht, Charles E / Fishbein, Daniel / Hanlon, Cathleen A / Lumlertdacha, Boonlert / Guerra, Marta / Meltzer, Martin I / Dhankhar, Praveen / Vaidya, Sagar A / Jenkins, Suzanne R / Sun, Benjamin / Hull, Harry F / Anonymous4930599. ·Preventive Medicine Residency, Office of Workforce and Career Development, CDC, USA. ·MMWR Recomm Rep · Pubmed #18496505.

ABSTRACT: These recommendations of the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations on human rabies prevention (CDC. Human rabies prevention--United States, 1999: recommendations of the Advisory Committee on Immunization Practices. MMWR 1999;48 [No. RR-1]) and reflect the status of rabies and antirabies biologics in the United States. This statement 1) provides updated information on human and animal rabies epidemiology; 2) summarizes the evidence regarding the effectiveness/efficacy, immunogenicity, and safety of rabies biologics; 3) presents new information on the cost-effectiveness of rabies postexposure prophylaxis; 4) presents recommendations for rabies postexposure and pre-exposure prophylaxis; and 5) presents information regarding treatment considerations for human rabies patients. These recommendations involve no substantial changes to the recommended approach for rabies postexposure or pre-exposure prophylaxis. ACIP recommends that prophylaxis for the prevention of rabies in humans exposed to rabies virus should include prompt and thorough wound cleansing followed by passive rabies immunization with human rabies immune globulin (HRIG) and vaccination with a cell culture rabies vaccine. For persons who have never been vaccinated against rabies, postexposure antirabies vaccination should always include administration of both passive antibody (HRIG) and vaccine (human diploid cell vaccine [HDCV] or purified chick embryo cell vaccine [PCECV]). Persons who have ever previously received complete vaccination regimens (pre-exposure or postexposure) with a cell culture vaccine or persons who have been vaccinated with other types of vaccines and have previously had a documented rabies virus neutralizing antibody titer should receive only 2 doses of vaccine: one on day 0 (as soon as the exposure is recognized and administration of vaccine can be arranged) and the second on day 3. HRIG is administered only once (i.e., at the beginning of antirabies prophylaxis) to previously unvaccinated persons to provide immediate, passive, rabies virus neutralizing antibody coverage until the patient responds to HDCV or PCECV by actively producing antibodies. A regimen of 5 1-mL doses of HDCV or PCECV should be administered intramuscularly to previously unvaccinated persons. The first dose of the 5-dose course should be administered as soon as possible after exposure (day 0). Additional doses should then be administered on days 3, 7, 14, and 28 after the first vaccination. Rabies pre-exposure vaccination should include three 1.0-mL injections of HDCV or PCECV administered intramuscularly (one injection per day on days 0, 7, and 21 or 28). Modifications were made to the language of the guidelines to clarify the recommendations and better specify the situations in which rabies post- and pre-exposure prophylaxis should be administered. No new rabies biologics are presented, and no changes were made to the vaccination schedules. However, rabies vaccine adsorbed (RVA, Bioport Corporation) is no longer available for rabies postexposure or pre-exposure prophylaxis, and intradermal pre-exposure prophylaxis is no longer recommended because it is not available in the United States.

5 Guideline Compendium of animal rabies prevention and control, 2008. 2008

Anonymous1420599. · ·J Am Vet Med Assoc · Pubmed #18479237.

ABSTRACT: -- No abstract --

6 Editorial Brexit has high stakes for Ireland too. 2018

Loeb, Josh. · ·Vet Rec · Pubmed #30217901.

ABSTRACT: -- No abstract --

7 Editorial WHO bites back rabies pre-travel vaccination schedules - Implications for travel medicine. 2018

De Pijper, Cornelis Adrianus / Stijnis, Cornelis / Grobusch, Martin Peter. ·Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. · Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. Electronic address: m.p.grobusch@amc.uva.nl. ·Travel Med Infect Dis · Pubmed #29698687.

ABSTRACT: -- No abstract --

8 Editorial Rabies-what is necessary to achieve 'zero by 30'? 2017

Durrheim, David N / Blumberg, Lucille. ·Public Health Medicine, University of Newcastle, Australia. · Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ·Trans R Soc Trop Med Hyg · Pubmed #29029281.

ABSTRACT: -- No abstract --

9 Editorial Global urbanization and the neglected tropical diseases. 2017

Hotez, Peter J. ·Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America. · James A Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America. · Department of Biology, Baylor University, Waco, Texas, United States of America. · Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, Texas, United States of America. ·PLoS Negl Trop Dis · Pubmed #28231246.

ABSTRACT: -- No abstract --

10 Editorial Rabies vaccine stockpile: fixing the supply chain. 2016

Abela-Ridder, Bernadette / Martin, Stephen / Gongal, Gyanendra / Engels, Dirk. ·Department of the Control of Neglected Tropical Diseases, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland . · Department of Pandemic and Epidemic Diseases, World Health Organization, Geneva, Switzerland . · Department of Health Security and Emergency Response, WHO Regional Office for South-East Asia, New Delhi, India . ·Bull World Health Organ · Pubmed #27708465.

ABSTRACT: -- No abstract --

11 Editorial CXCL10 and blood-brain barrier modulation in rabies virus infection. 2016

Gnanadurai, Clement W / Fu, Zhen F. ·Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA. · State-Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China. ·Oncotarget · Pubmed #26895109.

ABSTRACT: -- No abstract --

12 Editorial The dilemma of managing human rabies encephalitis. 2016

Warrell, M J. ·Oxford Vaccine Group, University of Oxford, Oxford, UK. ·Trop Med Int Health · Pubmed #26799263.

ABSTRACT: -- No abstract --

13 Editorial Animal Bites and Postexposure Rabies Prophylaxis. 2016

Gozdas, Hasan Tahsin. ·Department of Infectious Diseases and Clinical Microbiology, Dr. Munif Islamoglu Kastamonu State Hospital, Kastamonu, Turkey E-mail J Trop Pediatr · Pubmed #26721549.

ABSTRACT: -- No abstract --

14 Editorial Time to eliminate rabies. 2015

Anonymous860854. · ·Lancet · Pubmed #26738701.

ABSTRACT: -- No abstract --

15 Editorial Rabies: 100 per cent fatal, 100 per cent preventable. 2015

Abela-Ridder, B. ·Department of the Control of Neglected Tropical Diseases, World Health Organization, Avenue Appia 20, CH-1211, Genève 27, Switzerland e-mail: abelab@who.int. ·Vet Rec · Pubmed #26251539.

ABSTRACT: -- No abstract --

16 Editorial Imminent Departures: Rapid Vaccination Strategies Designed to Induce Short-Term Immunogenicity for the Trip at Hand. 2015

Freedman, David O. ·William C. Gorgas Center for Geographic Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA. · Shoreland Inc, Arlington, VA, USA. ·J Travel Med · Pubmed #26146818.

ABSTRACT: -- No abstract --

17 Editorial What is the true risk of imported dogs to the UK? 2015

Boyden, P. ·Veterinary Director, Dogs Trust, 17 Wakley Street, London EC1V 7RQ e-mail: paula.boyden@dogstrust.org.uk. ·Vet Rec · Pubmed #26113336.

ABSTRACT: -- No abstract --

18 Editorial Mass vaccination of dogs, control of canine populations and post-exposure vaccination--necessary but not sufficient for achieving childhood rabies elimination. 2015

Durrheim, D N / Rees, H / Briggs, D J / Blumberg, L H. ·School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia. ·Trop Med Int Health · Pubmed #25682707.

ABSTRACT: -- No abstract --

19 Editorial Rabies--an important zoonotic threat for travelers. 2014

Gautret, Philippe. ·Aix Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Unité Mixte de Recherche (UMR) 63, Centre National de la Recherche Scientifique (CNRS) 7278, Institut de Recherche pour le Développement (IRD) 198, Institut National de la Santé Et de la Recherche Médicale (INSERM) 1095, 13005 Marseille, France; Institut Hospitalo, Universitaire Méditerranée Infection, 13005 Marseille, France. Electronic address: philippe.gautret@club-internet.fr. ·Travel Med Infect Dis · Pubmed #25459429.

ABSTRACT: -- No abstract --

20 Editorial Rabies in Europe: what are the risks? 2014

Cliquet, Florence / Picard-Meyer, Evelyne / Robardet, Emmanuelle. ·French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Nancy Laboratory for Rabies and Wildlife, WHO Collaborating Centre for Research and Management in Zoonoses Control, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, OIE Reference Laboratory for Rabies, Technopôle agricole et vétérinaire de Pixérécourt, CS 40009, 54220 Malzéville, France. ·Expert Rev Anti Infect Ther · Pubmed #24847903.

ABSTRACT: Rabies remains a serious endemic disease in animal populations in many European countries. Oral vaccination by use of rabies vaccine baits has proved to be durably efficient for controlling and eliminating terrestrial rabies. However, the recurrence of rabies in some countries highlights the fragility of rabies-free country status and the need for continuous surveillance. In Eastern and Southern countries, the rabies control programmes for foxes should be accompanied by stray dog management measures in view of the high populations of strays in certain areas. Alerts of rabies in pets imported from enzootic countries are regularly reported in Europe, threatening the rabies-free status of terrestrial animals. New variants of rabies virus have been recently discovered in autochthonous bats, implying research studies to assess the efficacy of the current vaccines against those strains and the possible crossing of the species barrier in terrestrial mammals. The incidence of the disease in humans is very low, with cases contracted in Europe or in enzootic countries. Sustainable strategies of vaccination programmes in animals and improvement of public awareness, particularly for travelers, regarding rabies risks and legislation for pet movements would render accessible the elimination of rabies in Europe.

21 Editorial Human rabies in India: a problem needing more attention. 2014

Kole, Alakes Kumar / Roy, Rammohan / Kole, Dalia Chanda. ·Department of Medicine, Infectious Diseases Hospital 57, Beliaghata Main Road, Kolkata-700010, West Bengal, India . · BP Poddar Hospital & Medical Research Institute, Kolkata, India . ·Bull World Health Organ · Pubmed #24700986.

ABSTRACT: -- No abstract --

22 Editorial Recovery from rabies: a call to arms. 2014

Jackson, Alan C. ·Department of Internal Medicine (Neurology), University of Manitoba, Winnipeg, Manitoba, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: ajackson2@hsc.mb.ca. ·J Neurol Sci · Pubmed #24607333.

ABSTRACT: -- No abstract --

23 Editorial Taking the bite out of rabies, putting teeth into “One Health”. 2014

Fisman, David N. · ·Ann Intern Med · Pubmed #24592498.

ABSTRACT: -- No abstract --

24 Editorial Rabies: underused vaccines, unnecessary deaths. 2014

Dodet, Betty / Durrheim, David N / Rees, Helen. ·Director, Dodet Bioscience, Lyon, France. · University of Newcastle, Australia. Electronic address: David.Durrheim@newcastle.edu.au. · Executive Director, Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, South Africa. ·Vaccine · Pubmed #24434045.

ABSTRACT: -- No abstract --

25 Editorial Rabies: a deadly viral disease. 2013

Anonymous3930780. · ·Pathog Glob Health · Pubmed #24392674.

ABSTRACT: -- No abstract --

Next